Peak Hours News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Investing

IMF’s board approves second review of Ethiopia’s $3.4 billion program

by January 18, 2025
written by January 18, 2025

WASHINGTON (Reuters) – The executive board of the International Monetary Fund on Friday approved the second review of Ethiopia’s current financing program, the fund said, paving the way for a disbursement of about $250 million.

The East African nation struck the four-year, $3.4 billion program deal last July, after it undertook far-reaching reforms including the floatation of its birr currency, to enable it to try to put its debt restructuring back on track.

“The authorities continue their efforts to restore debt sustainability and are taking steps to secure a debt treatment. The progress made on debt restructuring negotiations under the Common Framework is welcome,” the IMF said in a statement.

“The financing assurances received, and adjustment efforts made are consistent with IMF policy requirements and program parameters.”

The Fund’s staff and the government reached agreement on the second review in late November.

The IMF has assessed that Ethiopia’s economy has fared better than expected under the reform program, with projected surge in inflationary pressure failing to materialise and hard currency reserves rising faster than the envisaged rate.

After unusually fast reviews of Ethiopia’s programme that were aimed at closely monitoring the impact of the reforms, the IMF said in November it would switch to the conventional six-month review schedule.

The IMF’s role in Ethiopia’s debt overhaul has come under criticism from some quarters, including from World Bank staff, who questioned the conclusions reached by the Fund’s debt sustainability assessment in an internal document last year.

This post appeared first on investing.com

0 comment
0
FacebookTwitterPinterestEmail

previous post
CBO sees US 2025 deficit flat at $1.9 trln before any Trump tax changes
next post
DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

You may also like

How billionaire Caltagirone could influence Italy’s banking M&A...

July 6, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

July 5, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

July 4, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

July 3, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

July 2, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

July 1, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

June 30, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

June 29, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

June 28, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

June 27, 2025
Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.









    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      July 6, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      July 5, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      July 4, 2025
    • Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

      July 4, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      July 3, 2025

    Categories

    • Economy (506)
    • Editor's Pick (10)
    • Investing (911)
    • Stock (798)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: peakhoursnews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Back To Top
    Peak Hours News
    • Investing
    • Stock
    • Economy
    • Editor’s Pick